Novartis
Researchers hope their study will show that tests for gene variants and DNA methylation can predict which lower-risk patients may be cured without a stem cell transplant.
Becton Dickinson, Navigate BioPharma Collaborate on Flow Cytometry Companion Diagnostics Development
The partners will offer their combined expertise to biopharma companies developing diagnostics and clinical decision-making tools.
Industry Groups Form European Coalition to Push for Better Comprehensive Genomic Profiling Access
A coalition of a trade group and drugmakers and diagnostics firms aims to share best practices and recommendations for better test reimbursement and uptake.
PerkinElmer, Novartis Collaborate on Sickle Cell Disease Screening in Sub-Saharan Africa
PerkinElmer will provide training, consultations, support, and other services to the effort, as well as establish new laboratory facilities.
Precision Cancer Consortium Launches With Bayer, GSK, Roche, Novartis as Founding Members
The organization of pharmaceutical and biotechnology firms aims to increase access to genomic testing for cancer patients.